Cathie Wood Beam Therapeutics Inc. Transaction History
Ark Investment Management LLC
- $11 Billion
- Q2 2024
A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 7,626,139 shares of BEAM stock, worth $178 Million. This represents 1.63% of its overall portfolio holdings.
Number of Shares
7,626,139
Previous 8,182,174
6.8%
Holding current value
$178 Million
Previous $270 Million
33.91%
% of portfolio
1.63%
Previous 1.93%
Shares
15 transactions
Others Institutions Holding BEAM
# of Institutions
230Shares Held
73.6MCall Options Held
283KPut Options Held
233K-
Farallon Capital Management LLC San Francisco, CA7.91MShares$185 Million0.9% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$185 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$179 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL5.44MShares$127 Million74.72% of portfolio
-
State Street Corp Boston, MA3.49MShares$81.7 Million0.0% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.65B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...